Rchr
J-GLOBAL ID：202001020351983474
Update date: Feb. 01, 2024
Shiraki Yukihiro
シラキ ユキヒロ | Shiraki Yukihiro
Affiliation and department：
Job title：
Assistant Professor
Other affiliations (2)：
Research field (2)：
Human pathology
, Experimental pathology
Research theme for competitive and other funds (2)：
- 2022 - 2026 神経変性疾患における疾患抑制性血管周囲線維芽細胞の機能解析と治療への応用
- 2018 - 2021 Functional analysis of CD109 in Brain Tumor.
Papers (51)：
-
Ryota Ando, Yukihiro Shiraki, Yuki Miyai, Hiroki Shimizu, Kazuhiro Furuhashi, Shun Minatoguchi, Katsuhiro Kato, Akira Kato, Tadashi Iida, Yasuyuki Mizutani, et al. Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas. The Journal of pathology. 2023
-
Takayuki Inoue, Bin Fu, Miwako Nishio, Miyako Tanaka, Hisashi Kato, Masashi Tanaka, Michiko Itoh, Hajime Yamakage, Kozue Ochi, Ayaka Ito, et al. Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis. Nutrients. 2023. 15. 2. 350
-
Kazuki Nakai, Hancheng Lin, Shotaro Yamano, Shinya Tanaka, Sho Kitamoto, Kenta Sakuma, Junpei Kurauchi, Eilma Akter, Masamitsu Konno, Jun Koseki, et al. Wnt activation-induced disturbance of cell competition causes diffuse invasion of transformed cells through upregulation of NF-κB-mediated MMP21. 2022
-
迫田 朋佳, 江崎 寛季, 安藤 良太, 宮井 雄基, 飯田 忠, 松山 誠, 白木 之浩, 三井 伸二, 西田 佳弘, 高橋 雅英, et al. 骨肉腫におけるMeflin陽性細胞を標的とした抗体薬物複合体の研究開発(An Effective Therapy that Antibody-Drug Conjugates Targeting Meflin(+) Cells for Osteosarcoma). 日本癌学会総会記事. 2022. 81回. E-2021
-
大脇 貴之, 宮井 雄基, 飯田 忠, 江崎 寛季, 白木 之浩, 三井 伸二, 榎本 篤. Meflinは尿路上皮癌における免疫チェックポイント阻害剤治療の効果予測バイオマーカーである(Meflin is a good predictive biomarker for ICI in urothelial carcinoma). 日本癌学会総会記事. 2022. 81回. P-2185
ｍore...
MISC (5)：
-
大脇貴之, 宮井雄基, 飯田忠, 江崎寛季, 白木之浩, 三井伸二, 榎本篤. Meflin is a good predictive biomarker for ICI in urothelial carcinoma. 日本癌学会学術総会抄録集(Web). 2022. 81st
-
迫田朋佳, 江崎寛季, 江崎寛季, 安藤良太, 宮井雄基, 飯田忠, 松山誠, 白木之浩, 三井伸二, 西田佳弘, et al. An Effective Therapy that Antibody-Drug Conjugates Targeting Meflin (+) Cells for Osteosarcoma. 日本癌学会学術総会抄録集(Web). 2022. 81st
-
山崎慎太郎, 大岡史治, 平野雅規, 平野雅規, 白木之浩, 本村和也, 棚橋邦明, 辻内高士, 本村絢子, 青木恒介, et al. Patient-derived meningioma organoid model demonstrates FOXM1 dependent tumor proliferation. 日本脳腫瘍学会プログラム・抄録集. 2021. 39th
-
山崎慎太郎, 大岡史治, 平野雅規, 本村和也, 棚橋邦明, 竹内和人, 白木之浩, 青木恒介, 北野詳太郎, 清水浩之, et al. Newly Established Meningioma Organoid Model Elucidated an Important Role of FOXM1 in Meningioma Progression. 日本脳腫瘍学会プログラム・抄録集. 2020. 38th
-
村瀬 陽太, 滝 哲郎, 土山 真里, 白木 之浩, 鈴木 康彦, 小野 謙三. 未分化癌からなる壁在結節を伴う卵巣粘液性腫瘍の1例. 陶生医報. 2014. 29. 39-42
Education (1)：
- 2013 - 2017 Nagoya University Graduate School of Medicine Program in Integrated Medicine
Work history (2)：
- 2017/06 - 現在 Nagoya University Graduate School of Medicine Division for Medical Research Engineering Assistant Professor
- 2017/04 - 現在 Nagoya University Graduate School of Medicine Program in Integrated Medicine Tumor Pathology
Association Membership(s) (2)：
The Japanese Cancer Association
, The Japanese Society of Pathology
